{"id":170332,"date":"2023-03-04T11:39:20","date_gmt":"2023-03-04T08:39:20","guid":{"rendered":"https:\/\/www.enerjigazetesi.ist\/?p=170332"},"modified":"2023-03-04T11:39:20","modified_gmt":"2023-03-04T08:39:20","slug":"rusya-devlet-nukleer-enerji-kurulusu-rosatom-izotop-urunlerini-tanitti","status":"publish","type":"post","link":"https:\/\/www.enerjigazetesi.ist\/en\/rusya-devlet-nukleer-enerji-kurulusu-rosatom-izotop-urunlerini-tanitti\/","title":{"rendered":"(Turkish) Rusya Devlet N\u00fckleer Enerji Kurulu\u015fu ‘Rosatom’ \u0130zotop \u00dcr\u00fcnlerini Tan\u0131tt\u0131"},"content":{"rendered":"

Sorry, this entry is only available in Turkish<\/a>. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.<\/p>

<\/p>\n

Rusya\u2019n\u0131n tek ve d\u00fcnyan\u0131n en b\u00fcy\u00fck t\u0131bbi izotop \u00fcreticilerinden biri olan Rusya Devlet N\u00fckleer Enerji Kurulu\u015fu Rosatom, n\u00fckleer t\u0131p konusuna a\u011f\u0131rl\u0131k vererek bu alandaki yetkinliklerini geli\u015ftirmeyi s\u00fcrd\u00fcr\u00fcyor. Rosatom, ocak ay\u0131nda Avrupa\u2019n\u0131n en b\u00fcy\u00fck radyofarmas\u00f6tik fabrikas\u0131n\u0131n in\u015faat\u0131na ba\u015flad\u0131. Bu yeni tesis, kardiyovask\u00fcler ve n\u00f6rodejeneratif hastal\u0131klar\u0131n ve kanserlerin te\u015fhis ve tedavisinde ilgi g\u00f6ren maddelerin Rusya taraf\u0131ndan \u00fcretimini art\u0131racak.<\/h2>\n

\"\"Rusya\u2019n\u0131n Obninsk kentinde, Rosatom\u2019un i\u015ftiraki Karpov Fizik ve Kimya Bilimsel Ara\u015ft\u0131rma Enstit\u00fcs\u00fc\u2019ne (NIFHI) ait arazide<\/strong> in\u015fa edilen tesisin, 2025 y\u0131l\u0131nda i\u015fletime al\u0131nmas\u0131 planlan\u0131yor. \u00a021 \u00fcretim hatt\u0131na sahip olan tesiste, onlarca yeni radyofarmas\u00f6tik<\/strong> ve aktif farmas\u00f6tik madde<\/strong> \u00fcretilecek. Bunlar aras\u0131nda \u00e7ok ra\u011fbet g\u00f6ren iyot- 131, samaryum-153 ve molibden-99<\/strong> gibi izotoplar<\/strong> da yer al\u0131yor. Tesiste, l\u00fctesyum-177, aktinyum-225, radyum-223<\/strong> ve di\u011fer izotoplara dayal\u0131 aktif radyofarmas\u00f6tik maddeler<\/strong> ve ila\u00e7lar da<\/strong> \u00fcretilecek.<\/p>\n

N\u00fckleer teknolojiler, hastal\u0131klar\u0131n te\u015fhis ve tedavisinde \u00f6nemli rol oynuyor<\/strong><\/h3>\n

D\u00fcnyan\u0131n hemen her yerinde, her mevsim, gece g\u00fcnd\u00fcz, b\u00fcy\u00fck miktarlarda enerji sa\u011flayabilen n\u00fckleer, enerji \u00fcretimi dendi\u011finde ilk akla gelen teknoloji olsa da pek \u00e7ok hastal\u0131\u011f\u0131n te\u015fhis<\/strong> ve tedavisinde<\/strong> kullan\u0131l\u0131yor.<\/p>\n

Bilgisayarl\u0131 tomografi (CT)<\/strong> ve mamografi, Pozitron-Emisyon-Tomografisi (PET), ultrason<\/strong> ve manyetik rezonans g\u00f6r\u00fcnt\u00fcleme (MRI)<\/strong> gibi tekniklerin kullan\u0131lmas\u0131n\u0131 sa\u011flayan n\u00fckleer teknoloji, hastal\u0131\u011f\u0131n te\u015fhis edilmesinin yan\u0131 s\u0131ra tedavi<\/strong> ve hastal\u0131k s\u00fcrecinde<\/strong> verilen tepkinin izlenmesini de sa\u011fl\u0131yor.<\/p>\n

\u00d6zellikle, \u00f6l\u00fcm nedenleri aras\u0131nda kardiyovask\u00fcler hastal\u0131klardan<\/strong> sonra ikinci s\u0131rada gelen kanserin te\u015fhisinde<\/strong> yayg\u0131n olarak kullan\u0131lan n\u00fckleer teknoloji<\/strong>, ya\u015fam kalitesini art\u0131rmas\u0131 yan\u0131 s\u0131ra radyoizotop<\/strong> ile radyasyon teknolojilerini kullan\u0131m\u0131yla<\/strong> s\u00fcrd\u00fcr\u00fclebilir kalk\u0131nma hedeflerine ula\u015fma konusunda \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n

Rosatom, izotop \u00fcretiminde \u00f6nc\u00fc \u015firketler aras\u0131nda<\/strong><\/h3>\n

Rosatom, d\u00fcnyada l\u00fctesyum-177 i\u00e7in kaynak malzeme olarak kullan\u0131lan iterbiyum-176 ve l\u00fctesyum-176 izotoplar\u0131n\u0131n ticari \u00fcretimini ba\u015flatan \u00f6nc\u00fc \u015firketler aras\u0131nda bulunuyor. Bununla beraber \u015firket \u00e7al\u0131\u015fanlar\u0131, ameliyat edilmesi m\u00fcmk\u00fcn olmayan t\u00fcm\u00f6r ve metastazlar\u0131n tedavisine y\u00f6nelik geli\u015fmi\u015f, hedefli radyofarmas\u00f6tiklerin \u00e7o\u011funda bulunan l\u00fctesyum-177 i\u00e7in bir dizi \u00fcretim y\u00f6ntemi geli\u015ftiriyor ve bunlar\u0131 hayata ge\u00e7iriyor.<\/p>\n

L\u00fctesyum-177 \u015fu anda Rosatom\u2019a ba\u011fl\u0131 iki kurulu\u015f taraf\u0131ndan elde ediliyor. K\u00fcresel anlamda, bu izotopu i\u00e7eren radyofarmas\u00f6tiklerin<\/strong> yakla\u015f\u0131k y\u00fczde 30<\/strong>\u2019u, Rus men\u015feli ham maddelerden \u00fcretiliyor. Aktinyum-225<\/strong> ise, t\u0131pk\u0131 l\u00fctesyum-177<\/strong> gibi, prostat kanseri benzeri, ameliyat edilemeyen metastatik kanserlerin tedavisi i\u00e7in<\/strong> en \u00e7ok umut veren bir ba\u015fka izotop<\/strong> olarak kabul ediliyor.<\/p>\n

Radyofarmas\u00f6tikler genellikle, n\u00f6roendokrin t\u00fcm\u00f6rlerin, myeloid bozukluklar\u0131n\u0131n, i\u00e7 organ ve kemik kanserlerinin, beyin t\u00fcm\u00f6rlerinin, dayan\u0131kl\u0131 (solid) t\u00fcm\u00f6rlerin, n\u00f6roblastoma, Non- Hodgkin lenfoma vb. hastal\u0131klar\u0131n tedavisinde kullan\u0131l\u0131yor.<\/p>\n

Rosatom, izotop \u00fcr\u00fcnleri tedarikinde i\u015f birli\u011fi yap\u0131yor<\/strong><\/h3>\n

Hindistan\u2019da ge\u00e7en ay d\u00fczenlenen 8. Uluslararas\u0131 Radyoizotoplar ve Radyasyon Teknolojileri Konferans\u0131<\/strong> NICSTAR-2023<\/strong>‘te, izotop \u00fcr\u00fcnlerini tan\u0131tan Rosatom, izotop \u00fcr\u00fcnleri tedarikinde<\/strong> i\u015f birli\u011fini geli\u015ftirmek \u00fczere Hintli ortaklarla bir\u00e7ok ba\u015far\u0131l\u0131 g\u00f6r\u00fc\u015fme<\/strong> ger\u00e7ekle\u015ftirdi.<\/p>\n

\u00d6nde gelen end\u00fcstri \u015firketlerini, devlet dairelerini ve uluslararas\u0131 kurulu\u015flar\u0131 temsil eden 15 \u00fclkeden 100’den fazla uzman\u0131 bir araya getiren konferansa ili\u015fkin a\u00e7\u0131klama yapan \u0130zotop-B\u00f6lgesel \u0130ttifak A.\u015e<\/strong>\u2019nin ticari i\u015flerden sorumlu Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131 Anton Shargin<\/strong> \u015f\u00f6yle konu\u015ftu:<\/span><\/p>\n

\u201cRosatom ve Hindistan uzun s\u00fcredir yak\u0131n bir i\u015f birli\u011fi y\u00fcr\u00fct\u00fcyor. Rosatom’un en geli\u015fmi\u015f n\u00fckleer teknolojilerin tamam\u0131na sahip olmas\u0131, taraflar aras\u0131nda pek \u00e7ok alanda, \u00f6zellikle de izotoplar konusunda kar\u015f\u0131l\u0131kl\u0131 faydaya dayanan ortakl\u0131\u011f\u0131n geli\u015ftirilece\u011fine inanmam\u0131z\u0131 sa\u011fl\u0131yor.\u201d<\/em><\/p>\n

\u0130zotop \u00fcr\u00fcnlerine y\u00f6nelik k\u00fcresel talep her ge\u00e7en y\u0131l art\u0131yor. Radyoizotoplar, onkolojik, kardiyolojik<\/strong> ve di\u011fer hastal\u0131klar\u0131n te\u015fhis<\/strong> ve tedavisinin<\/strong> yan\u0131 s\u0131ra g\u0131da \u00fcr\u00fcnlerinin sterilizasyonu, t\u0131bbi cihazlar ve malzemeler de dahil olmak \u00fczere end\u00fcstride ve bilimde yayg\u0131n olarak kullan\u0131l\u0131yor. Rosatom’un uluslararas\u0131 pazardaki resmi izotop \u00fcr\u00fcnleri tedarik\u00e7isi<\/strong> olan \u0130zotop-B\u00f6lgesel \u0130ttifak A.\u015e<\/strong> halihaz\u0131rda Hindistan da dahil olmak \u00fczere 50<\/strong> \u00fclkede 100’den fazla<\/strong> yabanc\u0131 \u015firkete izotop tedarik ediyor.<\/p>\n

Bu arada, Rusatom Healthacare A.\u015e<\/strong>\u2019nin b\u00fcnyesindeki Isotope A.\u015e, Ermenistan Cumhuriyeti’<\/strong>ne GT-5K teknesyum-99m jenerat\u00f6rleri<\/strong> ve Kazakistan\u2019a germanyum-68\/galyum-68 jenerat\u00f6rleri<\/strong> tedariki i\u00e7in de yeni s\u00f6zle\u015fmeler imzalad\u0131.<\/p>","protected":false},"excerpt":{"rendered":"

Sorry, this entry is only available in Turkish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Rusya\u2019n\u0131n tek ve d\u00fcnyan\u0131n en b\u00fcy\u00fck t\u0131bbi izotop \u00fcreticilerinden biri olan Rusya Devlet N\u00fckleer Enerji Kurulu\u015fu Rosatom, n\u00fckleer t\u0131p konusuna a\u011f\u0131rl\u0131k vererek […]<\/p>\n","protected":false},"author":1,"featured_media":170335,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53,43],"tags":[19356,35481,108038,108041,108039,108040,2587,108037],"views":58,"_links":{"self":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/170332"}],"collection":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/comments?post=170332"}],"version-history":[{"count":0,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/170332\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media\/170335"}],"wp:attachment":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media?parent=170332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/categories?post=170332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/tags?post=170332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}